Archive for: surprise billing

  • ORIGINAL ANALYSIS

  • PDF DOWNLOAD

  • EXTERNAL LINK

  • POST

Insight: original analysis

McDermottPlus Check-Up: February 28, 2020

The Administration requested emergency funding to fight the coronavirus epidemic, and US Department of Health and Human Services (HHS) Secretary Alex Azar defended the President’s fiscal year (FY) 2021 budget on Capitol Hill.

ORIGINAL ANALYSIS

Insight: original analysis

Surprise Billing Background and Comparison – Updated February 25, 2020

Surprise billing legislation has continued into 2020 with the introduction of two new surprise billing proposals in early 2020.

POST

Insight: original analysis

McDermottPlus Check-Up: February 14, 2020

House committees advanced legislation to address surprise billing, and the White House released the President’s budget for fiscal year (FY) 2021.

ORIGINAL ANALYSIS

Insight: original analysis

McDermottPlus Check-Up: January 31, 2020

The House of Representatives returned from recess to continue work on legislation to address surprise medical bills and high drug costs, while the Administration unveiled a proposal to let states opt for Medicaid block grants. The Senate remained busy with impeachment proceedings.

ORIGINAL ANALYSIS

Insight: original analysis

McDermottPlus Check-Up: January 17, 2020

The House of Representatives voted to formally present the articles of impeachment against President Trump to the Senate, kicking off the trial phase of the impeachment process. The Senate trial is expected to tie-up and stall legislation in the upper chamber for several weeks, and perhaps longer. House lawmakers, meanwhile, continued to grapple with surprise…

ORIGINAL ANALYSIS

Insight: original analysis

Health Policy Breakroom Ep. 08: 2020 Forecast, Drug Pricing and Surprise Billing

Rodney Whitlock and Rachel Stauffer offer a deep dive into what 2020 has in store for the issues of drug pricing and surprise billing.

ORIGINAL ANALYSIS

Insight: original analysis

McDermottPlus Check-Up: January 10, 2020

Congress is back in session following the holiday recess, though the exact Senate schedule remains uncertain as lawmakers negotiate the details of President Trump’s impeachment trial.

ORIGINAL ANALYSIS

Insight: original analysis

McDermottPlus Check-Up: December 20, 2019

The 2019 legislative session has come to an end. Lawmakers reached a deal to fund the government through fiscal year (FY) 2020, the House of Representatives impeached President Trump, and a federal appeals court issued a highly anticipated ruling with implications for the Affordable Care Act (ACA).

ORIGINAL ANALYSIS

Insight: original analysis

McDermottPlus Check-Up: December 13, 2019

House Democrats passed a sweeping drug pricing reform package and key House and Senate committees announced a surprise billing deal.

ORIGINAL ANALYSIS

Insight: original analysis

McDermottPlus Check-Up: December 06, 2019

Congress is back in town with just two weeks to address government funding and many healthcare issues. More proposals are emerging on drug pricing and surprise billing, and the House Judiciary Committee took up impeachment.

ORIGINAL ANALYSIS

Insight: original analysis

Health Plans from Top Democratic Presidential Candidates: A Comparison

Healthcare remains a pressing concern for voters heading into the 2020 presidential election. Many of the Democratic candidates have put forward detailed policy proposals for expanding healthcare access and affordability. The table below offers a broad overview of the healthcare plans proposed by the major contenders in the 2020 Democratic Primary, focusing on coverage, affordability,…

ORIGINAL ANALYSIS

Insight: original analysis

McDermottPlus Check-Up: October 4, 2019

This Week’s Dose: The impeachment inquiry proceedings are still moving forward, despite the Congressional recess. Surprise billing activity continued, and the Trump Administration issued an Executive Order on Medicare.

ORIGINAL ANALYSIS

Insight: original analysis

McDermottPlus Check-Up: September 20, 2019

This Week’s Dose: Speaker Pelosi released her long-awaited drug pricing bill, and the House Energy and Commerce Committee questioned drug companies’ financial motivations during a hearing this week.

ORIGINAL ANALYSIS

Insight: original analysis

McDermottPlus Check-Up: July 26, 2019

This Week’s Dose: The Senate Finance Committee finally released its drug pricing package and moved quickly to a markup. The bill passed out of committee, but work will continue before the full Senate votes. We’ll be watching closely as things develop.

ORIGINAL ANALYSIS

Insight: original analysis

What’s Next for the House Surprise Billing Package?

There has been a surge of congressional activity relating to the various surprise billing proposals. What started out as an issue for a small Senate working group last year has turned into a major health priority for both parties in both chambers.

ORIGINAL ANALYSIS

Insight: original analysis

McDermottPlus Health Care Preview: July 22, 2019

This is the last scheduled week the House is in session and the second to last week the Senate is in session before the August recess.  What will get done?

ORIGINAL ANALYSIS

Insight: original analysis

McDermottPlus Check-Up: July 19, 2019

This Week’s Dose: The Energy and Commerce Committee held a marathon mark-up of 25 bills, including 10 health care related bills. The No Surprises Act received an amendment that adds arbitration to the payment dispute process. The House voted to repeal the Cadillac tax. And, we finally have a Congressional Budget Office (CBO) score for…

ORIGINAL ANALYSIS

Insight: original analysis

McDermottPlus Check-Up: July 12, 2019

This Week’s Dose: Congress is back for the final legislative session before the August recess, and it’s all about what can get done ahead of the break. House and Senate committees have already advanced a cost containment legislation that includes surprise billing and prescription drug cost provisions, among many other things. We still await any…

ORIGINAL ANALYSIS

Insight: original analysis

Surprise Billing Primer

“Surprise billing” describes unexpected or unexpectedly high charges for medical services arising when an insured individual receives care, sometimes unknowingly, from an out-of-network provider.

ORIGINAL ANALYSIS

Insight: original analysis

McDermottPlus Check-Up: June 21, 2019

This Week’s Dose: Three weeks down, one week to go in this work period. The Senate Health, Education, Labor and Pensions (HELP) Committee is moving forward with its cost containment legislation, and the House passed the first batch of health care extenders.

ORIGINAL ANALYSIS

Insight: original analysis

Key Changes in HELP’s Updated Lower Health Care Costs Act

On June 19, 2019, the US Senate Committee on Health, Education, Labor & Pensions (HELP) released its updated Lower Health Care Costs Act (S. 1895). This new version includes several noteworthy changes, outlined below.

ORIGINAL ANALYSIS

Insight: original analysis

McDermottPlus Check-Up: June 14, 2019

This Week’s Dose: The focus was back on surprise billing this week with the third hearing of the year. We also saw hearings on Medicare for All and vertical consolidation in the health care industry, and the House advanced an appropriations package.

ORIGINAL ANALYSIS

Insight: original analysis

McDermottPlus Check-Up: June 7, 2019

This Week’s Dose: Congress is back, and this week marked the start of another busy legislative session. Work continues on drug pricing, surprise billing and cost containment, and negotiations have begun on an extenders package as well.

ORIGINAL ANALYSIS

Insight: original analysis

McDermottPlus Check-Up: May 10, 2019

This Week’s Dose: Another busy week for prescription drug pricing. Two more hearings took place on the subject, and a handful of bills passed out of the House. Now we watch the Senate to see how it packages and advances prescription drug bills that have moved through the House.

ORIGINAL ANALYSIS

Insight: original analysis

McDermottPlus Check-Up: April 5, 2019

This Week’s Dose: Health care continues to dominate much of the attention on Capitol Hill. Lots of hearings. New coverage expansion legislation. And more state action on Medicaid.

ORIGINAL ANALYSIS

Load more
beakernav X1E2BFA62-BFCE-43C1-B777-27E3E5216018medical bagoriginal analysis +external linkpdf downloadstethoscope